Consequences of reducing hypoglycemia-inducing glucose-lowering medication (medication that lowers glucose (sugar) levels in the blood and can cause low blood sugar) in people with type 2 diabetes of 70 years or older
Not Applicable
- Conditions
- Complications of type 2 diabetesNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN50008265
- Lead Sponsor
- Amsterdam University Medical Centers
- Brief Summary
2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/39049109/ (added 29/07/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 404
Inclusion Criteria
1. Age 70 years or older
2. Having type 2 diabetes
3. Using insulin or sulfonyl urea derivative drugs
4. Recent Hba1c below 54 mmol/ mol or if deemed fragile by the GP practice below 58mmol/mol
Exclusion Criteria
Previously having indicated to be not willing to participate in studies using routine care electronic data
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Two year follow up count of all ICPC coded reasons of encounter registered in the routine care electronical register of the GP practice that are potentially related to hypoglycemia selected in a Delphi procedure by three GP's.
- Secondary Outcome Measures
Name Time Method